Page last updated: 2024-08-16

ro 31-8220 and pep005

ro 31-8220 has been researched along with pep005 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Akdeniz, Ö; Erin, N; Isca, VMS; Rijo, P; Tavşan, E1

Other Studies

1 other study(ies) available for ro 31-8220 and pep005

ArticleYear
Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKCδ and PKCε activators.
    Cytokine, 2021, Volume: 142

    Topics: Alkanes; Animals; Bryostatins; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL2; Chemokines; Cyclopropanes; Diterpenes; Enzyme Activators; Extracellular Signal-Regulated MAP Kinases; Female; Indoles; Mammary Neoplasms, Animal; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Kinase C-delta; Protein Kinase C-epsilon; Receptors, Interleukin-8B

2021
chemdatabank.com